Zdrowie i gospodarka · 19/12/2005
FDA Amends Animal Drug Regulations for Tiamulin
The FDA is updating its regulations to reflect a change in sponsorship for four new animal drug applications for tiamulin, from Boehringer Ingelheim Vetmedica to Novartis Animal Health US.
Source: Federal Register — Food and Drug AdministrationOpen original release →